The COVID-19 pandemic continues to affect efforts to combat TB and presents challenges for TB programs. This collection shares recent webinars, articles, and other resources focusing on the implications of COVID-19 on TB prevention, diagnosis, and treatment.
USAID recently celebrated the second anniversary of the Global Accelerator to End Tuberculosis. The virtual event included a panel of speakers sharing successes and challenges in the fight to end TB. The importance of facing the COVID-19 pandemic while remaining committed to ending TB was a common thread throughout the discussion.
TB DIAH was in the midst of preparing to implement the QTSA methodology and tools in Afghanistan when the COVID-19 pandemic began its global spread. The United States Agency for International Development (USAID) mission in Afghanistan requested additions to the QTSA to help assess the effects of COVID-19 on TB services in the country, demonstrating the importance and viability of modifying existing tools in the fight against both COVID-19 and TB.
TB DIAH staff shared work from the project’s Quality of TB Services Assessment (QTSA) findings at the recent 51st Union World Conference on Lung Health. This article includes a recap of TB DIAH’s participation and shares reflections from attendees.
How can cascade analysis be used to improve planning for tuberculosis (TB) programs? This article by TB DIAH’s Ersin Topcuoglu, MD, MPH, explains how the TB cascade of care can serve as a valuable data source for analysis, which ultimately helps inform strategic, managerial, and operational decision making. This improved project and program planning helps narrow gaps within the TB cascade of care.
MEASURE Evaluation, funded by the United States Agency for International Development (USAID), initiated a series of Quality of TB Services Assessments (QTSAs) to evaluate the quality of TB services in randomly selected health facilities in a number of USAID TB priority countries. TB DIAH will be continuing this work and extending assessments to countries in Africa, Asia, and Europe.
TB programs face multiple challenges as the COVID-19 pandemic continues to affect efforts to combat TB. This collection shares recent webinars, guidance documents, and other resources that shed light on the implications of COVID-19 on TB prevention, diagnosis, and treatment.
A best practice in facilitating tuberculosis (TB) data analysis and use is the cascade method for finding gaps in programs. Cascades quantify, track, and visualize how health and development programs are performing for the target population at progressive stages toward an expected outcome. They reveal weaknesses at stages of TB control and help program and project managers recognize unacceptable variations among different disaggregation levels and refine targeted TB activities for implementation. Ersin Topcuoglu, MD, MPH, explains.
As the world has awakened to the urgent need to stem the COVID-19 virus and mount an aggressive and creative defense, those veterans of the tuberculosis (TB) fight have ideas and skills that should be deployed. In the spirit of cooperation and aligned interests, we offer here recent papers and resources that shed light on the implications of COVID-19 on TB prevention, diagnosis, treatment.
The United States Agency for International Development (USAID) has been a leader in the global fight against tuberculosis (TB) for more than two decades, funding anti-TB efforts in more than 50 countries. USAID’s Global Accelerator to End TB aims to support priority country ministries of health through delivery of technical expertise to increase TB and multi drug-resistant TB (MDR-TB) diagnosis and treatment; strengthen local TB organizations; speed the transition of sustainable funding and management of TB programs to governments; and improve coordination of TB programs with other health programs. Helping countries interpret and manage their data to fight TB is a key focus.